Skip to content
Search

Latest Stories

Mental Health: Pandemic Induced Poor Mental Health Is “Invisible Killer”

The coronavirus pandemic has not just impacted people’ physical health but also their mental wellbeing, health secretary Sajid Javid said in his address at the Global Mental Health Summit 2021 on Tuesday (September 5).

Calling poor mental health an “invisible killer” Javid said: “Around 1 in 5 adults in Britain experienced some form of depression in the first 3 months of this year. That’s over double the figure before we started our fight against Covid-19.”


Poor mental health induced by the pandemic led to more people seeking help across the world.

Citing a survey by the World Health Organization (WHO), he said the pandemic disrupted mental health services in 93 per cent of countries worldwide.

To tackle the situation and help people, in England 24/7 crisis hotlines were set up that have received 3 million calls since the start of the pandemic.

Besides, the government have committed an extra £2.3 billion per year to transform mental health services in the country by 2023.

He added: “We’ve also strengthened mental health support for colleagues on the frontline, and we’re reforming our Mental Health Act to make sure that everyone is treated with respect that they deserve.”

Javid urged people to talk more openly about their mental health and wellbeing.

He said: “We know that, for every person who comes forward, there are more who’re suffering in silence. So we must keep encouraging people to get help if they need it and keep working to eliminate the stigma that’s far too often attached to mental health so that people know it’s OK not to be OK.”

He added that mental health issues must be “treated with the same urgency as physical health.”

Javid highlighted that disparities in mental health are often linked with other disparities such as economic background.

“In the UK, children from the poorest 20 per cent of households are 4 times as likely to have serious mental health difficulties by the age of 11 compared with those from the wealthiest 20 per cent of households.”

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less